Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Human Cloning Policy Institute Spearheads Global Grassroots Effort to Prevent Therapeutic Cloning Ban at the United Nations

06.11.2003


The Human Cloning Policy Institute (HCPI) launched this week a major grassroots effort to head off a proposed ban on therapeutic cloning in the United Nations scheduled for vote this Thursday. The total ban is sponsored by Costa Rica and is supported by the United States. The Human Cloning Policy Institute is backed by Ian Wilmut (Dolly’s cloner), some of the world’s leading scientists, physicians and international law experts, including retired World Court judge, C.G. Weeramantry.

HCPI executive director, Bernard Siegel stated, “It is the widespread belief of leading scientists and medical researchers that failure to proceed with SCNT stem cell research is the equivalent to turning our backs on one of the greatest potential medical advances of our time and would thereby destroy the hope for understanding and treatment of many deadly diseases and conditions. A consequence of banning SCNT research might be to condemn millions of adults and children to premature death or a life of intense misery and suffering.”

HCPI has urged its supporters and allied organizations, including disease advocates, private citizens, members of biotechnology organizations, physicians, lawyers and members of the scientific research community, to support passage of UN initiatives outlawing human reproductive cloning, but which allow for the promise of SCNT. It opposes the Costa Rican proposed convention, which bans SCNT research and urges support for the rival Belgium compromise convention, which encourages member states to ban reproductive cloning, but would not ban SCNT internationally.



HCPI further urges support for the World Court Initiative asking the General Assembly to seek an advisory opinion from the International Court of Justice declaring human reproductive cloning (only) a crime against humanity. Siegel stated, “By sponsoring the World Court Initiative, HCPI seeks that the World Court strip away any vestige of legitimacy from potential human cloners, such as Zavos and Antinori. A declaration that human reproductive cloning is a crime against humanity will prompt all member states to crack down on those activities and serve as a lasting deterrent.”

Siegel further commented, “Human reproductive cloning activities performed by unscrupulous scientists are human experimentation. No individual scientist, corporation, business enterprise or nation has the moral or legal warrant to clone human beings. It is extremely important to recognize the difference between reproductive and therapeutic cloning. Informed scientific opinion worldwide supports therapeutic cloning of stem cells. The American Medical Association, the National Academy of Sciences, the Association of American Universities, and many other medical, scientific, and educational associations endorse therapeutic cloning.”

Supporters of HCPI have been urged to email the UN missions at mission@un.org, to express their views on the current proposals. Organizations allied with HCPI on this initiative include the Stem Cell Action Network (SCAN) which has emailed a petition to all UN missions, signed by 2,200 teachers and scientists in medical schools and university science departments across the United States in favor of therapeutic cloning research. The Committee for Advancement of Stem Cell Research (CASCR) also supports the initiative. Both organizations are members of the Coalition for the Advancement of Medical Research.

Frank Cocozzelli, CASCR executive director, who suffers from a form of muscular dystrophy said, “Along with millions of other world citizens who are disabled, suffering from a catastrophic illness or both, SCNT offers me one of the first real rays of hope of being healed.”

The Human Cloning Policy Institute (HCPI) is a nonprofit organization dedicated to advocacy, education and policies against reproductive cloning, while preserving SCNT (therapeutic cloning) which holds the promise of understanding and treating some of man’s deadliest diseases.

HCPI’s principal supporters are leading stem cell scientists, researchers and physicians, who are members of the group’s science and medical advisory boards. A partial list includes: Dr. Ian Wilmut (Roslin Institute), Dr. Rudolf Jaenisch (Whitehead Institute- MIT), Dr. Douglas Melton (Harvard), Dr. Lawrence Goldstein (UCSD), Dr. Gerald Schatten (Magee College), Dr. Alan Trounson ( Monash- Australia), Camillo Ricordi, MD (Diabetes Research Institute), Dr. Helena Edlund (Sweden), Dr. W.Dalton Dietrich (Miami Project to Cure Paralysis), Joe Massey, MD. (Reproductive expert-Atlanta), Judith Grossberg, M.D. (pediatrics-MCV),Doris Rapp, MD ( best-selling author), Sidney Ikpe (International Hospital Relief Foundation), Torrey Brown, MD (Intralytix, Inc., Baltimore) and Dr. Barry Smernoff (Cleveland).

HCPI also has the support of a human rights-legal advisory board that includes retired World Court Judge Christopher Weeramantry (Sri Lanka), law professor Richard Falk (Princeton-UCSB), Peter Ludwig (Darby & Darby-New York) and Nihal Jayawickrama (University of London, School of Economics).

Bernard Siegel | alfa
Further information:
http://www.clonelaw.org

More articles from Health and Medicine:

nachricht Diabetes mellitus: A risk factor for early colorectal cancer
27.05.2020 | Nationales Centrum für Tumorerkrankungen (NCT) Heidelberg

nachricht Ultra-thin fibres designed to protect nerves after brain surgery
27.05.2020 | Martin-Luther-Universität Halle-Wittenberg

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Biotechnology: Triggered by light, a novel way to switch on an enzyme

In living cells, enzymes drive biochemical metabolic processes enabling reactions to take place efficiently. It is this very ability which allows them to be used as catalysts in biotechnology, for example to create chemical products such as pharmaceutics. Researchers now identified an enzyme that, when illuminated with blue light, becomes catalytically active and initiates a reaction that was previously unknown in enzymatics. The study was published in "Nature Communications".

Enzymes: they are the central drivers for biochemical metabolic processes in every living cell, enabling reactions to take place efficiently. It is this very...

Im Focus: New double-contrast technique picks up small tumors on MRI

Early detection of tumors is extremely important in treating cancer. A new technique developed by researchers at the University of California, Davis offers a significant advance in using magnetic resonance imaging to pick out even very small tumors from normal tissue. The work is published May 25 in the journal Nature Nanotechnology.

researchers at the University of California, Davis offers a significant advance in using magnetic resonance imaging to pick out even very small tumors from...

Im Focus: I-call - When microimplants communicate with each other / Innovation driver digitization - "Smart Health“

Microelectronics as a key technology enables numerous innovations in the field of intelligent medical technology. The Fraunhofer Institute for Biomedical Engineering IBMT coordinates the BMBF cooperative project "I-call" realizing the first electronic system for ultrasound-based, safe and interference-resistant data transmission between implants in the human body.

When microelectronic systems are used for medical applications, they have to meet high requirements in terms of biocompatibility, reliability, energy...

Im Focus: When predictions of theoretical chemists become reality

Thomas Heine, Professor of Theoretical Chemistry at TU Dresden, together with his team, first predicted a topological 2D polymer in 2019. Only one year later, an international team led by Italian researchers was able to synthesize these materials and experimentally prove their topological properties. For the renowned journal Nature Materials, this was the occasion to invite Thomas Heine to a News and Views article, which was published this week. Under the title "Making 2D Topological Polymers a reality" Prof. Heine describes how his theory became a reality.

Ultrathin materials are extremely interesting as building blocks for next generation nano electronic devices, as it is much easier to make circuits and other...

Im Focus: Rolling into the deep

Scientists took a leukocyte as the blueprint and developed a microrobot that has the size, shape and moving capabilities of a white blood cell. Simulating a blood vessel in a laboratory setting, they succeeded in magnetically navigating the ball-shaped microroller through this dynamic and dense environment. The drug-delivery vehicle withstood the simulated blood flow, pushing the developments in targeted drug delivery a step further: inside the body, there is no better access route to all tissues and organs than the circulatory system. A robot that could actually travel through this finely woven web would revolutionize the minimally-invasive treatment of illnesses.

A team of scientists from the Max Planck Institute for Intelligent Systems (MPI-IS) in Stuttgart invented a tiny microrobot that resembles a white blood cell...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Dresden Nexus Conference 2020: Same Time, Virtual Format, Registration Opened

19.05.2020 | Event News

Aachen Machine Tool Colloquium AWK'21 will take place on June 10 and 11, 2021

07.04.2020 | Event News

International Coral Reef Symposium in Bremen Postponed by a Year

06.04.2020 | Event News

 
Latest News

Biophysicists reveal how optogenetic tool works

29.05.2020 | Life Sciences

Convenient location of a near-threshold proton-emitting resonance in 11B

29.05.2020 | Physics and Astronomy

Mapping immune cells in brain tumors

29.05.2020 | Life Sciences

VideoLinks
Science & Research
Overview of more VideoLinks >>>